ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan approves first trials of stem cell-based heart treatment

iPS procedure raises hopes for alternative to donations and artificial organs

Osaka University professor Yoshiki Sawa outlines his plans for treating heart failure in 2017. (Photo by Hiromasa Matsuura)

TOKYO -- Japan is set to host the world's first clinical trials involving the use of induced pluripotent stem (iPS) cells to treat heart failure. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more